The overall list of identified metabolites is presented in Table 2. Table 2 List of the intracellular metabolites identified after GC-MS analysis. We have observed that both growth conditions (i.e., dilution rates) and the genetic characteristics of E. coli strains (i.e., presence/absence of the relA gene deletion) induced Inhibitors,research,lifescience,medical significant alterations in the metabolite profiles of bacterial cultures, though the number of metabolites that had their levels significantly different depending

on the dilution rate was slightly higher than when comparing E. coli strains (16 and 14 metabolites, respectively). Still, nine metabolites were commonly altered in both experimental conditions, indicating that metabolic states of Selleck Ku0059436 cultures were profoundly affected in both cases. Almost 50% of the total metabolites were detected at significantly different levels in the mutant strain compared to the

Inhibitors,research,lifescience,medical wild-type (Figure 1), meaning that, at the same steady state conditions, at least half of Inhibitors,research,lifescience,medical the detected metabolites presented significant differences in their abundances when comparing the two cultures. This suggests that enzymatic activities involving these metabolites are somehow influenced by this single mutation, leading to alterations in their levels. For instance, significant changes in amino and fatty acids levels, in particular tetradecanoate (ttdca, n-C14:0), pentadecanoate (pdca, n-C15:0), 10,13-dimethyltetradecanoate (1013mlt), octadecanoate (ocdca, n-C18:0), isoleucine (ile), threonine (thr), aspartate (asp) and glutamate (glu) were observed. Other metabolites that revealed interesting Inhibitors,research,lifescience,medical differences include N-acetyl-L-glutamate (acglu), lysine

(lys), malate (mal), alpha-ketoglutarate (akg), itaconate (itcon) and malonate (ma); that were uniquely detected in the E. coli W3110 Inhibitors,research,lifescience,medical culture at a dilution rate of 0.1 h−1 (see Figure S1). Although these were not retrieved as statistically significant in the Mack-Skillings’s test, since they were not detected in any other samples, they may contribute to the differentiation between the metabolic behavior of W3110 and relA cultures. These metabolites almost are essentially associated with amino acid biosynthetic activities or metabolic regulation, like the itaconate (itcon) and malonate (ma), known to be enzymatic inhibitors of the isocitrate lyase, an enzyme associated with the glyoxylate cycle. Figure 1 Venn diagram showing the list of the intracellular metabolites that were significantly changed (p-value < 0.01) according to either factors: A (i.e., E. coli strain) or B (i.e., dilution rate). Besides differences in metabolite levels, we have paid attention to the changes in metabolite profiles produced by each E. coli strain at different dilution rates.